A Lightning Bolt Technology to Cure Chronic Venous Disease: Success Story of Penumbra’s Medical Devices

24 Aug 2023

Penumbra, an original equipment manufacturer (OEM) based in California, has consistently been a major player in the MedTech industry. The reason for this success is the integration of high-tech medical devices in the company portfolio for chronic venous disease(CVD) treatment. 

According to the BIS Research report, the global deep venous disease treatment devices market has huge potential. It was valued at $1,119.3 million in 2022 and is anticipated to reach $2,419.2 million by 2032, witnessing a CAGR of 7.72% during the forecast period 2023-2032. By tapping into this market, medical OEMs and MedTech companies can reap the benefits of the growing market value.
 


Click here to download a FREE sample

This article covers the success story of deep venous disease treatment devices launched by Penumbra.

Lightning Flash

In January 2023, Penumbra launched Lightning Flash, an innovative mechanical thrombectomy system designed to address venous and pulmonary thrombus. This technology combines a superior catheter design with a dual clot detection innovation, making it the most advanced system available in the market.  

The Lightning Flash system incorporates Penumbra's Lightning Intelligent Aspiration technology, equipped with dual clot detection algorithms. This enables physicians to efficiently remove large blood clots from the body, including venous thrombus and pulmonary emboli. Moreover, this technology offers exceptional trackability and can differentiate between flowing blood and blood clots, ensuring a safer procedure.

Penumbra is significantly growing by tapping the potential of the venous disease treatment devices market. Specialty clinics and hospitals are increasingly using Penumbra’s medical devices. 

The lightning flash device is powered by the Penumbra ENGINE, which employs pressure and flow-based algorithms to detect blood clots and blood flow accurately. Its catheter is made of MaxID hypotube technology, which offers a larger inner diameter similar to large-bore catheters while maintaining a lower profile with a soft, atraumatic tip, facilitating navigation through complex and delicate anatomy. This combination allows for quick clot removal while minimizing potential blood loss.  

The enhanced technology enables physicians to remove a broad spectrum of blood clots swiftly and with less invasiveness compared to existing interventional or surgical methods, benefiting a larger number of patients.

Moreover, Lightning Flash is a part of Penumbra's Indigo System with Lightning portfolio and is currently the only computer-aided mechanical thrombectomy system available in the U.S. Early data has shown promising improvements in clinical outcomes and patients' quality of life.

Lightning Bolt 7

In June 2023, Penumbra introduced Lightning Bolt 7, the most advanced arterial thrombectomy system, utilizing modulated aspiration and superior catheter design for rapid blood clot removal in a single session. 

This technology combines Penumbra's Lightning Intelligent Aspiration with an advanced microprocessor algorithm, efficiently removing large, fibrous blood clots from arteries while minimizing blood loss in conditions such as acute limb ischemia, hibernating thrombus, and visceral occlusions. 

Conclusion 

In the future, the healthcare industry can expect more sophisticated and minimally invasive devices that offer improved precision and efficacy in treating deep venous conditions. 

Innovations such as computer-aided algorithms and artificial intelligence will enhance diagnostic accuracy, ensuring better patient outcomes. Medical devices in the future will combine multiple modalities, such as advanced catheter designs, targeted drug delivery, and novel clot removal techniques, to provide comprehensive and personalized treatment options. 

Moreover, ongoing research and clinical trials will continually refine these devices, making deep venous disease management more efficient, safe, and accessible for patients worldwide. 

Interested to know more about the growing technologies in your industry vertical? Get the latest market studies and insights from BIS Research. Connect with us at [email protected] to learn and understand more.

 
 
 

OUR CLIENTS